The role of viruses in the cancerogenesis
DOI:
https://doi.org/10.20883/medical.e60Keywords:
cancers, cancerogensis, virusesAbstract
It is estimated that seven key viruses such as Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human T-lymphotropic virus (HTLV), Human papilloma viruses (HPV), Kaposi’s sarcoma-associated herpes-virus (KSHV), Epstein-Barr virus (EBV) and Merkel cell polyomavirus (MCV), are responsible for about 11% of cancers all over the world. Viruses however are not only associated with cancerogenesis process. Scientific researches from recent years emphasize the possible use of the microorganisms as antitumor therapy. Oncoviruses, also defined as tumor viruses cause cancers whereas oncolytic viruses infect the host’s cancer cells leading to destruction of tumor and due to that they are described as cancer killing viruses. It offers the potential application of viral infections to the cancer therapy.Downloads
References
Danaei G. Global burden of infection-related cancer revisited. Lancet Oncol. 2012;13:564–5.
Chang MH, You SL, Chen CJ, Liu CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101:1348–55.
Horzinek MC. The birth of virology. Antonie Van Leeuwenhoek. 1997;71:15–20.
Lecoq H. Discovery of the first virus, the tobacco mosaic virus: 1892 or 1898? C R AcadSci III. 2001;324:929–33.
Rous P. Landmark article (JAMA 1911;56:198). Transmission of a malignant new growth by means of a cell-free filtrate. By Peyton Rous. JAMA. 1983;250:1445–9.
Raju TN. The Nobel chronicles. 1966: Francis Peyton Rous (1879–1970) and Charles Brenton Huggins (1901–97). Lancet. 1999;354:520.
MacLeod CM. Richard Edwin Shope, 1901–1966. Trans Assoc Am Physicians. 1971;84:36–8.
Gross L. The role of viruses in the etiology of cancer and leukemia in animals and in humans. Proc Natl Acad Sci USA. 1997;94:4237–8.
Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet. 1964;1:702–3.
Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, et al. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia.Nature. 1981;294:268–71.
Nie ufać dogmatom. Academia. Magazyn Polskiej Akademii Nauk. 2009;3; www.academia.pan.pl/dokonania.php?id=503, access date: 21.02.2012.
Weiner AJ, Wang KS, Choo QL, Gerin JL, et al. Hepatitis delta (delta) cDNA clones: undetectable hybridization to nucleic acids from infectious non-A, non-B hepatitis materials and hepatitis B DNA. J Med Virol. 1987;21: 239–47.
Schmidt C. Yuan Chang and Patrick Moore: teaming up to hunt down cancer-causing viruses. J Natl Cancer Inst. 2008;100:524–5,529.
Michaelis M, Doerr HW, Cinat lJ. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009;11:1–9.
Miller-Kittrell M, Sparer TE. Feeling manipulated: cytomegalovirus immune manipulation. Virol J. 2009;6:4.
Bender C, Zipeto D, Bidoia C, Costantini S, et al. Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer. 2009;4:6.
Tong AW, Senzer N, Cerullo V, Templeton NS, et al. Oncolytic Viruses for Induction, of Anti-Tumor Immunity. Curr Pharm Biotechnol. 2011.
Butt AQ, Miggin SM. Cancer & viruses: A double-edged sword. Proteomics. 2012, DOI: 10.1002/pmic.201100526.
Galanis E. Cancer: Tumour-fighting virus homes in. Nature. 2011;477:40–1.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. In J Cancer. 2006;118: 3030–44.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Michał Chojnicki, Mariola Pawlaczyk, Celina Helak-Łapaj, Jakub Żurawski, Krzysztof Wiktorowicz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
